KDR and neoplasm: In a renal cell carcinoma mouse model, treatment with Sunitinib, an inhibitor of receptor tyrosine kinase including VEGFR, arrested tumor growth, diminished angiogenesis and reduced both TAMs and Treg cells in the tumor [188].